Skip to content
Balance Sheet · TASI 8010

The Company for Cooperative Insurance
Cash and cash equivalents history.

Cash and near-cash balances reported at the reporting date. Explore 12 reported observations from 2023 to 2026, with every value linked to its official evidence.

Coverage2023–202612 source-linked periods
Annual history0annual reporting periods
Interim history12quarterly or year-to-date periods
StatementBalance Sheetas reported by the issuer
First-quarter series

Cash and cash equivalents

The series uses the same reporting duration and currency. The filing values appear below.

2026HISTORICALCash and cash equivalents1.61B SAR
Cash and cash equivalents0500M1B1.5B2B2023202420252026
Hover or tap to exploreSAR
Half-year series

Cash and cash equivalents

The series uses the same reporting duration and currency. The filing values appear below.

2026IFRS 17Cash and cash equivalents1.79B SAR
Cash and cash equivalents0500M1B1.5B2B2023202420252026
Hover or tap to exploreSAR
Nine-month series

Cash and cash equivalents

The series uses the same reporting duration and currency. The filing values appear below.

2026IFRS 17Cash and cash equivalents1.82B SAR
Cash and cash equivalents01B2B3B2023202420252026
Hover or tap to exploreSAR
Official evidence ledger

Every value, period and source.

Normalized values support comparison. The reported value and unit preserve the original filing presentation.

PeriodReported valueComparable valueReported lineEvidence
9M / Q3 20262026-09-301,820,23430 September 20261.82B SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
H1 / Q2 20262026-06-301,794,73130 June 20261.79B SARCash and cash equivalentsOfficial p. 4 ↗Open statement →
Q1 20262026-03-311,605,32631 March 2026 (Unaudited)1.61B SARCash and cash equivalentsNote 4Signed copy p. 4 ↗Saudi Exchange filing ↗Open statement →
9M / Q3 20252025-09-30969,91530 September 2025969.92M SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
H1 / Q2 20252025-06-30825,17330 June 2025 · SAR’000825.17M SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
Q1 20252025-03-311,439,64131 March 2025 · SAR’0001.44B SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
9M / Q3 20242024-09-302,073,61130 September 2024 · SAR’0002.07B SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
H1 / Q2 20242024-06-301,339,07130 June 2024 · SAR’0001.34B SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
Q1 20242024-03-311,801,45131 March 2024 · SAR’0001.8B SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
9M / Q3 20232023-09-302,591,25530 September 20232.59B SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
H1 / Q2 20232023-06-301,918,20430 June 20231.92B SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
Q1 20232023-03-311,473,32431 March 20231.47B SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
How to read this series

Reported first. Comparable second.

We show the original label and figure alongside its normalized value. Annual, first-quarter, half-year and nine-month series are separate. Per-share figures keep the issuer’s reported share basis.

سجل مالي موثق بالمصدر

التعاونية — Cash and cash equivalents

تُعرض القيم كما وردت في القوائم المالية الرسمية، مع فصل الفترات السنوية والمرحلية وربط كل قيمة بصفحة المصدر الرسمي. تُعرض ربحية السهم وفق أساس الأسهم الوارد في كل تقرير.